Odysight.ai CBO granted 15,000 stock options

Odysight.ai Inc. reported that Chief Business Officer Sagi Eilam received a grant of stock options covering 15,000 shares of common stock at an exercise price of $0.0000 per share.

Rhea-AI Filing Summary

Odysight.ai Inc. reported that Chief Business Officer Sagi Eilam received a grant of stock options covering 15,000 shares of common stock at an exercise price of $0.0000 per share. The options vest one-third on November 15, 2026 and then in equal quarterly installments through November 15, 2028.

Insider Trade Summary

Grant/Award: 15,000 shares

Grant/Award 1 txn

Insider Sagi Eilam

Role Chief Business Officer

Type	Security	Shares	Price	Value
Grant/Award	Options to purchase common stock (right to buy)	15,000	$0.00	$0.00

Holdings After Transaction: Options to purchase common stock (right to buy) — 15,000 contracts (Direct)

Footnotes (1)

1. F1. The stock option vests and becomes exercisable as to one-third of the total shares on November 15, 2026 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on November 15, 2028.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Odysight.ai (ODYS) report for Sagi Eilam?

Odysight.ai reported a grant of stock options to Chief Business Officer Sagi Eilam for 15,000 shares at an exercise price of $0.0000 per share, reflecting an equity compensation award rather than an open‑market share purchase or sale.

How many Odysight.ai (ODYS) stock options were granted to Sagi Eilam?

Sagi Eilam was granted options to purchase 15,000 shares of Odysight.ai common stock. These options represent a new equity award and increase his directly owned derivative holdings to 15,000 options following the reported transaction on February 19, 2026.

What is the exercise price of Sagi Eilam’s Odysight.ai (ODYS) stock options?

The granted stock options have an exercise price of $0.0000 per share. This means Eilam can acquire Odysight.ai common shares under this award without additional cash payment upon exercise, subject to the vesting schedule and other plan terms governing the options.

When do Sagi Eilam’s Odysight.ai (ODYS) stock options vest?

One-third of the stock options vest and become exercisable on November 15, 2026. The remaining options vest in equal quarterly installments over the following 24 months, so the award is fully vested and exercisable by November 15, 2028, according to the disclosure footnote.

Is Sagi Eilam buying or selling Odysight.ai (ODYS) shares in this Form 4?

The Form 4 reflects an acquisition of derivative securities through a grant of stock options, not an open‑market buy or sell. The transaction code is “A,” indicating a grant, award, or other acquisition of options to purchase common stock.

How many Odysight.ai (ODYS) options does Sagi Eilam hold after this grant?

Following this transaction, Sagi Eilam directly holds 15,000 stock options. This total reflects the newly granted options reported in the filing, which are subject to the multi‑year vesting schedule extending through November 15, 2028 as described in the accompanying footnote.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 04:05 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sagi Eilam

(Last) (First) (Middle)

C/O ODYSIGHT AI INC.

SUITE 7A, INDUSTRIAL PARK, P.O. BOX 3030

(Street)

OMER L3 8496500

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Odysight.ai Inc. [ ODYS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Business Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to purchase common stock (right to buy)	$5.14	02/19/2026		A		15,000		(1)	02/19/2036	Common Stock	15,000	$0	15,000	D

Explanation of Responses:

1. The stock option vests and becomes exercisable as to one-third of the total shares on November 15, 2026 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on November 15, 2028.

	/s/ Eilam Sagi	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.